Clinical Trials Directory

Trials / Completed

CompletedNCT01572402

Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Institute for Clinical and Experimental Medicine · Other Government
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Insulin secretion, plasma lipids, oxidative stress markers and gastrointestinal peptides will be measured in patients with type 2 diabetes versus healthy subjects in a fasting status and in response to standard meals (at times 0', 30', 60', 120' and 180').

Conditions

Interventions

TypeNameDescription
OTHERBagueutte Cheese Gourmet (Crocodille)180g, energy 452.8 Kcal/1895.7 kJ, composition: carbohydrates 49,2 g (44,55%), proteins 18,5 g (16,74%), lipids 18,8 g (38,7%), of which saturated 6,8 g, monounsaturated 6,0 g, polyunsaturated 5,0 g.
OTHERCous-cous sandwich235 g, energy 455,88 Kcal /1907,4 kJ, composition: carbohydrates 59,54 g (52,24%), proteins 12,47 g (10,57% %), lipids 18,85 g (37,31%), of which saturated 6,2 g, monounsaturated 11,49 g, polyunsaturated 28,26 g
OTHERMcCountry sandwich (McDonald's)150g, 455 kcal/1903,72 kJ, composition: carbohydrates 31 g (27,25%), proteins 24 g (21,1%), lipids 26 g (51,43%), of which saturated 10 g (38,45%)

Timeline

Start date
2012-01-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-04-06
Last updated
2012-05-10

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT01572402. Inclusion in this directory is not an endorsement.